Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.

Subscriber Content

Bayer Schering Launches MS Drug Betaferon

publication date: Sep 27, 2010

Bayer Schering announced the China launch of Betaferon® (interferon beta-1b), a treatment for relapsing-remitting forms of multiple sclerosis (MS). The drug received SFDA approval for distribution in China last December. Bayer has introduced several products recently as it strives to make good on its promise to increase its revenues at a better than 20% rate. More details....

Stock Symbol: (XETRA: BAY)

Sorry this page is available to subscribers only.If you're not a subscriber why not subscribe today?